Medical Advisory Committee

In addition to our Board of Directors, the Alport Syndrome Foundation is honored to have a team of four outstanding physicians on our Medical Advisory Committee. Each is a renowned clinician in the field of nephrology and has research interests and numerous publications in related topics. Our Medical Advisory Committee provides us with input and review of the clinical and scientific information provided on our website and helps us to identify emerging research opportunities that offer hope to understanding and treating this disease.

Gerald B. Appel, M.D., F.A.C.P., F.A.S.N.
Director of Clinical Nephrology
Columbia University College of Physicians and Surgeons
Consultant Physician and Director of Clinical Nephrology
New York-Presbyterian Hospital (New York, NY)

Dr. Gerald Appel is currently Director of Clinical Nephrology at New York Presbyterian Hospital, New York, NY, and is a tenured Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. He received his medical degree from Albert Einstein College of Medicine, Bronx, New York in 1972. He then went on to complete his internship and residency in internal medicine at Columbia Presbyterian Medical Center and his fellowship in nephrology at both Columbia-Presbyterian and Yale-New Haven Medical Center in New Haven, Connecticut. Dr. Appel has received numerous awards throughout his distinguished career, including being listed in the “Best Doctors in New York” and “Best Doctors in America” since 1992. He is board certified in internal medicine and nephrology and has published hundreds of articles and book chapters related to kidney disease. Dr. Appel is associate editor of Clinical JASN and of Up-To-Date. Dr. Appel has also served on the Medical Advisory Board and as the Chairman of the Research Committee of the National Kidney Foundation of New York and New Jersey and is a past President of the New York Society of Nephrology. In addition, Dr. Appel has been Chair of the Council of Glomerulonephritis of the National Kidney Foundation and served as Chair of the Clinical Grants Committee for the Kidney and Urological Foundation of America from 1995 to 2004.

Martin C. Gregory, B.M., B.Ch., D.Phil.
Professor of Medicine
Department of Internal Medicine
University of Utah School of Medicine (Salt Lake City, UT)

Dr. Martin Gregory is Professor of Medicine (Clinical) and Associate Division Chief, Division of Nephrology, University of Utah School of Medicine. He completed his medical school training at the University of Oxford in England in 1968. He then went on to complete his internship and residency in Nephrology in Paris, France at the Medecin Resident Etranger des Hopitaux and in Oxford, England at Churchill Hospital. Dr. Gregory has been a member of the faculty of the University of Utah, Division of Nephrology, since 1981. He is board certified in internal medicine and nephrology. Dr. Gregory has served on the editorial boards of the Archives of Internal Medicine, Journal of the American Society of Nephrology, Transactions of the American Society for Artificial Internal Organs, Kidney International, and New England Journal of Medicine. He has received numerous scholastic honors and has published hundreds of articles and book chapters related to Nephrology and the genetics of Alport Syndrome.

Ronald J. Hogg, M.B., Ch.B.
Pediatric Nephrology
Scott & White Medical Center (Temple, TX)

Dr. Ronald Hogg completed his medical training at Liverpool University Medical School in Liverpool, England and his residency and fellowship training at Hospital for Sick Children in Toronto, Canada. He attended Southwestern Medical School in Dallas, Texas for his nephrology training. Dr. Hogg is board certified by the American Board of Pediatrics and the American Board of Pediatric Nephrology. He is actively involved in numerous national and international clinical research organizations and founder of the Southwest Pediatric Nephrology Study Group (SPNSG), a multi-center collaborative dedicated to efforts aimed at improving the treatment of a wide array of renal disorders in children.

Clifford E. Kashtan, M.D., F.A.S.N.
Professor of Pediatrics
Division of Pediatric Nephrology
University of Minnesota (Minneapolis, MN)

Dr. Clifford Kashtan is Professor of Pediatrics (with tenure) at the University of Minnesota Medical School, and an attending Pediatric Nephrologist at the University of Minnesota Children’s Hospital-Fairveiw, in Minneapolis, Minnesota. He is board certified in Pediatrics and Pediatric Nephrology. He completed his medical school training at Wayne State University in Detroit, Michigan, his Pediatric residency at Boston City Hospital, and his Pediatric Nephrology fellowship at Massachusetts General Hospital and the University of Minnesota. He has been a member of the faculty of the University of Minnesota since 1987. He is a Fellow of the American Society of Nephrology and has served on the editorial boards of the Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation and Pediatric Nephrology. He has also served as a Councilor of the American Society of Pediatric Nephrology. Dr. Kashtan has authored numerous original research articles, reviews and book chapters on Alport Syndrome. He is also the author of the Alport Syndrome entries at the online resources UpToDate and GeneReviews. He has lectured on Alport Syndrome at numerous institutions and meetings, both nationally and internationally. Dr. Kashtan developed methods for diagnosing Alport Syndrome by examining type IV collagen chains in kidney and skin biopsies. Dr. Kashtan recently created the Alport Syndrome Treatments and Outcomes Registry (ASTOR), a new effort to facilitate studies of treatments for people with Alport Syndrome.